← Back to Search

Dietary Supplement

Beyond Hormone for Endocrine Disorder

N/A
Waitlist Available
Research Sponsored by Scale Media Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female at-birth, aged 25-45
Not menopausal or perimenopausal
Must not have
Use of hormonal contraceptives or hormone therapy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (day 0), midline (day 45), and endline (day 90)

Summary

"This trial will test Live Conscious's Beyond Hormone supplement in women to see if it can help regulate hormone production. 50 healthy women between 25-45 years old will participate in a three-month

Who is the study for?
This trial is for generally healthy women aged 25-45 who are not menopausal and may have an endocrine disorder affecting their hormone levels. Participants will be involved in the study for the duration of three menstrual cycles.
What is being tested?
The trial is testing 'Beyond Hormone,' a supplement by Live Conscious, against a placebo to see if it helps regulate hormone production. The study randomly assigns participants to receive either the supplement or placebo, without anyone knowing which they're getting (triple-blind).
What are the potential side effects?
Since specific side effects aren't listed, potential participants should ask about risks associated with taking 'Beyond Hormone.' Placebos typically don't cause side effects but can include symptoms due to expectation or psychological factors.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a woman aged between 25 and 45.
Select...
I am not going through menopause or perimenopause.
Select...
I am not taking any hormone-affecting drugs or supplements.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently using hormonal contraceptives or hormone therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (day 0), midline (day 45), and endline (day 90)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (day 0), midline (day 45), and endline (day 90) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hormone Levels Blood Panel (estradiol, testosterone, DHEA, insulin, and progesterone)
Secondary study objectives
Participants' Libido using a Libido Questionnaire
Participants' Monthly Cycle Symptoms using the Menstrual Cycle Symptom Diary (MCSD)
Participants' Mood and Energy Levels using the Visual Analog Scale (VAS)
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Beyond Hormone SupplementExperimental Treatment1 Intervention
Participants in this arm will receive the Beyond Hormone supplement.
Group II: PlaceboPlacebo Group1 Intervention
Participants in this arm will receive a placebo consisting of rice flour encapsulated in a vegetable cellulose capsule.

Find a Location

Who is running the clinical trial?

CitruslabsIndustry Sponsor
89 Previous Clinical Trials
4,680 Total Patients Enrolled
Scale Media IncLead Sponsor
4 Previous Clinical Trials
250 Total Patients Enrolled
~33 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top